IL46040A - 7(5,6-dihydro-1,4-dithin or oxathiin acetamido) cephalosporanic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

7(5,6-dihydro-1,4-dithin or oxathiin acetamido) cephalosporanic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL46040A
IL46040A IL46040A IL4604074A IL46040A IL 46040 A IL46040 A IL 46040A IL 46040 A IL46040 A IL 46040A IL 4604074 A IL4604074 A IL 4604074A IL 46040 A IL46040 A IL 46040A
Authority
IL
Israel
Prior art keywords
radical
carboxy
cephalosporin
methyl
salts
Prior art date
Application number
IL46040A
Other languages
English (en)
Other versions
IL46040A0 (en
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7340431A external-priority patent/FR2250517A1/fr
Priority claimed from FR7414436A external-priority patent/FR2268525A1/fr
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Publication of IL46040A0 publication Critical patent/IL46040A0/xx
Publication of IL46040A publication Critical patent/IL46040A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL46040A 1973-11-14 1974-11-12 7(5,6-dihydro-1,4-dithin or oxathiin acetamido) cephalosporanic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing the same IL46040A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7340431A FR2250517A1 (en) 1973-11-14 1973-11-14 Dihydro-dithiinyl-and-oxathiinyl-methyl cephalosporins - with broad-spectrum antibacterial activity
FR7414436A FR2268525A1 (en) 1974-04-25 1974-04-25 Dihydro-dithiinyl-and-oxathiinyl-methyl cephalosporins - with broad-spectrum antibacterial activity

Publications (2)

Publication Number Publication Date
IL46040A0 IL46040A0 (en) 1975-02-10
IL46040A true IL46040A (en) 1977-12-30

Family

ID=26218022

Family Applications (1)

Application Number Title Priority Date Filing Date
IL46040A IL46040A (en) 1973-11-14 1974-11-12 7(5,6-dihydro-1,4-dithin or oxathiin acetamido) cephalosporanic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing the same

Country Status (18)

Country Link
US (1) US4007176A (ru)
JP (1) JPS5082090A (ru)
AR (2) AR205728A1 (ru)
AT (1) AT335608B (ru)
CA (1) CA1026745A (ru)
CH (2) CH602762A5 (ru)
DE (1) DE2454109A1 (ru)
DK (1) DK590774A (ru)
ES (1) ES431943A1 (ru)
FI (1) FI330074A (ru)
GB (1) GB1430908A (ru)
HU (1) HU168853B (ru)
IE (1) IE40206B1 (ru)
IL (1) IL46040A (ru)
NL (1) NL7414486A (ru)
NO (1) NO744081L (ru)
SE (1) SE7414263L (ru)
SU (2) SU566525A3 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2338045A1 (fr) * 1976-01-19 1977-08-12 Rhone Poulenc Ind Nouveaux derives de la cephalosporine, leur preparation et les compositions qui les contiennent
GB1597848A (en) * 1976-12-27 1981-09-09 Fujisawa Pharmaceutical Co Cephalosporin compounds and processes for the preparation thereof
JPS53103493A (en) * 1977-02-18 1978-09-08 Takeda Chem Ind Ltd Cephalosporin derivatives and process for their preparation
CH648317A5 (de) * 1977-06-10 1985-03-15 Yamanouchi Pharma Co Ltd 7alpha-methoxy-7betha-(1,3-dithietan-2- carboxamido)cephalosporansaeurederivate und verfahren zu ihrer herstellung.
US4172941A (en) * 1978-05-12 1979-10-30 Richardson-Merrell Inc. 7-[2-[ω-(1,3-Dithiolan-2-imino)substituted]-acetylamino]cephalosporanic acid derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH527215A (de) * 1967-04-15 1972-08-31 Fujisawa Pharmaceutical Co Verfahren zur Herstellung von 3,7-disubstituierten Cephalosporinderivaten
US3692779A (en) * 1970-08-12 1972-09-19 Bristol Myers Co 7-{8 n-(substituted-imidoyl)aminoacetamide{9 cephalosporanic acids and derivatives thereof
US3886151A (en) * 1974-03-18 1975-05-27 American Home Prod 7-{8 2-(Heteroazinylthio)acetamido{9 {0 cephalosporanic acid derivatives

Also Published As

Publication number Publication date
AU7528474A (en) 1976-05-13
SE7414263L (ru) 1975-05-15
AT335608B (de) 1977-03-25
FI330074A (ru) 1975-05-15
GB1430908A (en) 1976-04-07
SU566525A3 (ru) 1977-07-25
DK590774A (ru) 1975-07-14
CH602762A5 (ru) 1978-07-31
NO744081L (ru) 1975-06-09
AR205398A1 (es) 1976-04-30
ES431943A1 (es) 1977-01-16
IE40206L (en) 1975-05-14
NL7414486A (nl) 1975-05-16
SU576947A3 (ru) 1977-10-15
IE40206B1 (en) 1979-04-11
AR205728A1 (es) 1976-05-31
CA1026745A (en) 1978-02-21
CH608499A5 (ru) 1979-01-15
US4007176A (en) 1977-02-08
ATA914274A (de) 1976-07-15
HU168853B (ru) 1976-07-28
JPS5082090A (ru) 1975-07-03
IL46040A0 (en) 1975-02-10
DE2454109A1 (de) 1975-05-15

Similar Documents

Publication Publication Date Title
US3828037A (en) Trifluoromethylmercaptoacetamidocephalosporins
DK159156B (da) Analogifremgangsmaade til fremstilling af (2-(2-aminothiazol-4-yl)-2-(0-substitueret)-oxyiminoacetamido)-7-cephalosporan-syre og fysiologisk acceptable salte deraf
JPH0257069B2 (ru)
KR19990064201A (ko) 세팔로스포린 항생제
DE3688087T2 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
CA1065854A (en) 7-acetoacetamidocephem compounds
IE69040B1 (en) Crystallized cephem-acid addition salts and a process for the preparation thereof
EP0746561B1 (en) Quinolonylcarboxamidocephalosporin derivatives and pharmaceutical compositions containing them
US4399132A (en) 7-Beta-[alpha-syn-methoxyimino-alpha-(2-aminothiazol-4-yl)-acetamido]-3-[(1,2,3-thiadiazol-5-ylthio)methyl]-3-cephem-4-carboxylic acid and C1 -C6 alkyl derivatives thereof
US4007176A (en) Cephalosporin derivatives
US4034090A (en) Cephalosporin derivatives
CA1274237A (en) O-substituted oximino cephalosporins
US3814755A (en) 7-(omikron-aminomethylphenylacetamido)-3-(tetrazolo(4,5-b)pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
Wheeler et al. Orally active esters of cephalosporin antibiotics. Synthesis and biological properties of acyloxymethyl esters of 7-(D-2-amino-2-phenylacetamido)-3-[5-methyl-(1, 3, 4-thiadiazol-2-yl) thiomethyl]-3-cephem-4-carboxylic acid
WO1989004313A1 (en) Cephalosporin antibiotics
DD204257A5 (de) Verfahren zur herstellung von cephalosporinen, die in position 3 substituiert sind
US4311842A (en) Cephalosporin compounds
US4088761A (en) 3-[(1,3-Dithiin-5-yl)-acetamido]-cephalosporins and antibacterial compositions containing them
US4034088A (en) Cephalosporin derivatives, and compositions containing them
EP0006011B1 (en) Cephalosporins and pharmaceutical compositions containing them
JPS6156238B2 (ru)
HU185685B (en) Process for preparing new cefem-carboxylic acid derivatives
US4201781A (en) Substituted 7[s-oxopyrido[2,3-d]pyrimidine carboxamido acetamido]cephalosporins
US4857521A (en) Trialkylsilyl pyridinium cephalosporin antibiotics
DK157686B (da) Analogifremgangsmaade til fremstilling af 7-beta-substituerede imidazolidinyl-3-chlor-3-cephem-4-carboxylsyrer eller farmaceutisk acceptable salte deraf